Morgan Lewis has advised Digital Colony, an investment firm focused on mobile and internet infrastructure, on its acquisition of Opencell, which expands presence in the United Kingdom. The transaction was signed on 1 November. Opencell provides multi-operator indoor mobile coverage for a variety of customers, building types, and sizes, particularly landlords and tenants using small cell infrastructure.   Morgan Lewis’s team was led by London partner Tom Cartwright and included associate Jack Shawdon, with support from partner Lee Harding and associates Nadia Akhter and Sarah Stock (employment) and associate Neil McKnight (tax).  

KPS Capital Partners’ (KPS) portfolio company C&D Technologies (C&D) has agreed to acquire Trojan Battery Company (Trojan) from Charlesbank Capital Partners, LLC and other shareholders.  Financial terms of the transaction have not been disclosed.   C&D’s acquisition of Trojan combines two leading specialty battery manufacturers with long histories of delivering the highest-quality, most-innovative products in the industrial, renewable energy and specialty motive markets. The combined company will be a global technology leader in the battery industry, with over USD1.0 billion of revenue, and the ability to provide a wide portfolio of high quality energy storage solutions to meet the growing needs

Chicago-based private equity firm Frontenac has acquired Motion Solutions, a provider of highly engineered linear motion, motion control and automation solutions for critical, high technology applications. Financial terms of the private transaction have not been disclosed.   Headquartered in Aliso Viejo, CA, Motion Solutions pushes the limits of motion technology in partnership with innovative OEMs by utilising extensive mechanical and electrical engineering expertise alongside manufacturing, distribution and assembly capabilities. The company specialises in technical engineered systems for sophisticated applications that require precise, reliable and customised movement. Motion Solutions’ products are sold as individual components or assembled into complex systems to

Affiliates of CVC Fund VII (CVC) are to acquire ConvergeOne Holdings, a global IT and managed services provider of collaboration and technology solutions, in an all-cash transaction valued at approximately USD1.8 billion.   Subject to customary closing conditions and regulatory approvals, ConvergeOne expects the transaction to close in the fourth quarter of 2018 or the first quarter of 2019. ConvergeOne will maintain its corporate headquarters in Eagan, MN and continue to be led by its current executive team.   Pursuant to the terms of the merger agreement, affiliates of CVC will commence a tender offer for all of the outstanding

Lew’s Holdings Corporation (Lew’s), a supplier of fishing and hunting products, has acquired Southern Plastics Company, a manufacturer of soft plastic fishing lures. Southern Plastics is a leading manufacturer of soft plastic lures utilising a unique variety of scents, additives, and colours supported by industry leading operational capabilities. Southern Plastics has manufactured soft plastics for Strike King for over twenty years. Based in Eufaula, Alabama, Southern Plastics benefits from an exceptional team of managers and employees.   Peter Leibman, Managing Director of Peak Rock Capital, says: “We are excited about the opportunity to partner with one of the industry’s best-known manufacturers

Private equity firm Avista Capital Partners (Avista) is to acquire G&W Laboratories’ extended topicals and dermatology business unit (G&W Dermatology). The transaction does not involve G&W Labs’ other businesses, including investments to drive efficiency in the pharmaceutical value chain and contract manufacturing operations in Sellersville, PA and Lincolnton, NC.    G&W Dermatology has a market-leading and diversified portfolio of approximately 35 self-labelled generic topical dermatology products that are currently marketed and sold in the US. In addition, the Company maintains partnership arrangements on a number of products and is a contract manufacturer for select products owned by other pharmaceutical companies.